Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Pittsburgh › NPI 1285667493
Clinic

West Penn Allegheny Health System INC.

West Penn Allegheny Health System INC. was paid $10.81M by Medicaid between Jan 2018 and Dec 2024, across 306 billing codes. Its largest line is 99285, emergency room visit (most serious) — 20% of everything it billed.

33Billing provider infoWEST PENN ALLEGHENY HEALTH SYSTEM INC.
PITTSBURGH, PA 15212
33aNPI1285667493assigned 07/09/2006
33bProvider typeNon-Surgical Family Planning Clinic/Center
28Total paid$10.81M
24GClaims379,040
24DCodes billed306
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Non-Surgical Family Planning Clinic/Center providers in Pennsylvania

Rank by total paid#1 of 5
Median peer was paid$61K
This provider vs. median176×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018295$8K
20191,860$38K
202057,906$1.35M
2021193,784$5.43M
202249,183$1.49M
202345,774$1.47M
2024incomplete30,238$1.02M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 20% 14,551 13,623 $2.20M
G0378 Hospital observation service, per hour 14% 1,698 1,546 $1.50M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 9,740 9,393 $1.48M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 8,969 8,649 $1.22M
A0431 Ambulance service, conventional air services, transport, one way (rotary wing) 3.5% 126 120 $374K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 3.0% 7,149 3,409 $324K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.8% 3,855 3,676 $308K
87536 1.6% 1,257 1,236 $168K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 1,571 1,513 $157K
0002A 1.2% 3,091 3,065 $131K
0001A 1.1% 3,274 3,257 $117K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.1% 2,836 2,745 $115K
294 more codes
80053 Comprehensive metabolic panel 1.0% 14,517 $111K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,011 $106K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,843 $97K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 26,535 $93K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,190 $90K
A0436 Rotary wing air mileage, per statute mile <1% 130 $86K
70450 Computed tomography, head or brain; without contrast material <1% 1,838 $65K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,990 $64K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 243 $54K
84443 Thyroid stimulating hormone (TSH) <1% 2,019 $49K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 719 $47K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 392 $46K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,465 $45K
80048 Basic metabolic panel (calcium, ionized) <1% 8,958 $45K
71275 Computed tomographic angiography, chest, with contrast material <1% 471 $45K
80050 General health panel <1% 827 $44K
80061 Lipid panel <1% 2,770 $43K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,691 $42K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 8,619 $41K
77067 Screening mammography, bilateral, including computer-aided detection <1% 419 $41K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,096 $40K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 985 $39K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 706 $39K
97161 <1% 966 $34K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 684 $32K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 869 $32K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 556 $32K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 116 $31K
88184 <1% 743 $31K
0225U <1% 186 $30K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 622 $30K
88185 <1% 950 $28K
70496 <1% 312 $27K
72125 Computed tomography, cervical spine; without contrast material <1% 661 $27K
87481 <1% 526 $26K
86803 <1% 1,501 $25K
29581 <1% 1,667 $25K
96375 Therapeutic injection; each additional sequential IV push <1% 2,678 $23K
0031A <1% 644 $23K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 199 $22K
70498 <1% 289 $21K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 140 $21K
84484 <1% 3,500 $18K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,388 $18K
84702 <1% 2,235 $17K
71250 <1% 302 $16K
83036 Hemoglobin; glycosylated (A1C) <1% 2,211 $16K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 55 $16K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 903 $16K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 587 $16K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 101 $15K
71045 Radiologic examination, chest; single view <1% 4,080 $15K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 214 $14K
86780 <1% 766 $13K
83735 <1% 2,647 $13K
93971 <1% 262 $13K
71046 Radiologic examination, chest; 2 views <1% 1,408 $13K
87522 Neg quan hep c or qual rna <1% 296 $12K
76642 <1% 261 $12K
97165 <1% 539 $12K
86834 <1% 42 $12K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 267 $11K
83880 <1% 622 $11K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 682 $11K
86835 <1% 42 $10K
84466 <1% 632 $10K
84439 <1% 1,034 $9K
36415 Collection of venous blood by venipuncture <1% 10,133 $9K
85610 <1% 3,469 $9K
72141 <1% 40 $9K
87340 <1% 527 $9K
85027 <1% 1,440 $9K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 60 $9K
96361 Intravenous infusion, hydration; each additional hour <1% 1,189 $9K
77063 Screening digital breast tomosynthesis, bilateral <1% 335 $9K
82607 <1% 807 $9K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 304 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,243 $8K
95886 <1% 148 $8K
80076 <1% 1,185 $8K
93970 <1% 129 $8K
87205 <1% 1,518 $7K
70486 <1% 177 $7K
84153 <1% 280 $7K
84403 <1% 207 $7K
82728 <1% 627 $7K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 46 $6K
86850 <1% 1,105 $6K
97162 <1% 261 $6K
83970 <1% 136 $6K
0100U <1% 161 $6K
84100 <1% 1,314 $5K
82570 <1% 671 $5K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 57 $5K
86360 <1% 77 $5K
83540 <1% 650 $5K
87040 <1% 403 $5K
82043 <1% 499 $5K
85730 <1% 1,511 $5K
83690 <1% 1,957 $5K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 212 $5K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 64 $4K
96376 <1% 752 $4K
82784 <1% 173 $4K
77336 <1% 97 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 328 $4K
81001 <1% 2,491 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 42 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 36 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,314 $4K
80299 <1% 236 $4K
82805 <1% 252 $4K
86359 <1% 77 $4K
73610 <1% 336 $4K
83615 <1% 659 $4K
82550 <1% 777 $4K
87070 <1% 639 $4K
88342 <1% 110 $4K
74174 <1% 15 $3K
86357 <1% 77 $3K
73030 <1% 350 $3K
86355 <1% 77 $3K
73560 <1% 441 $3K
90715 <1% 1,050 $3K
87186 <1% 506 $3K
86706 <1% 221 $3K
93975 <1% 41 $3K
86900 <1% 1,110 $3K
86901 <1% 1,105 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 317 $3K
84999 <1% 788 $3K
73130 <1% 373 $3K
73630 <1% 440 $3K
86038 <1% 153 $3K
83605 <1% 834 $3K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 24 $3K
86762 <1% 102 $3K
87081 <1% 560 $3K
85379 <1% 559 $3K
84550 <1% 444 $3K
81003 <1% 1,177 $2K
83001 <1% 99 $2K
87075 <1% 309 $2K
80197 <1% 223 $2K
0003A <1% 109 $2K
77066 Tomosynthesis, mammo <1% 33 $2K
86140 <1% 876 $2K
72100 <1% 137 $2K
77334 <1% 23 $2K
86480 <1% 26 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 61 $2K
86255 <1% 79 $2K
76536 <1% 39 $2K
76830 Ultrasound, transvaginal <1% 42 $2K
84402 <1% 61 $2K
93922 <1% 76 $2K
86592 <1% 401 $2K
70491 <1% 43 $2K
86704 <1% 102 $2K
J2704 Injection, propofol, 10 mg <1% 7,055 $2K
85652 <1% 782 $2K
93017 <1% 118 $2K
87077 <1% 325 $2K
J3490 Unclassified drugs <1% 4,602 $2K
73502 <1% 174 $2K
72040 <1% 127 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,127 $2K
82565 <1% 295 $2K
62323 <1% 13 $2K
82746 <1% 183 $2K
76942 <1% 138 $1K
73590 <1% 184 $1K
72131 <1% 42 $1K
73110 <1% 201 $1K
82962 <1% 1,720 $1K
86618 <1% 56 $1K
80320 <1% 208 $1K
88341 <1% 16 $1K
74018 <1% 173 $1K
84146 <1% 41 $1K
80348 <1% 23 $1K
81025 <1% 744 $1K
A9270 Non-covered item or service <1% 34,581 $1K
C1769 Guide wire <1% 252 $992.87
97164 <1% 27 $971.68
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,747 $961.56
97597 <1% 28 $955.73
84145 <1% 150 $934.35
82553 <1% 228 $890.65
76775 <1% 26 $841.85
83516 <1% 71 $816.19
72128 <1% 24 $791.71
87147 <1% 271 $786.93
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,363 $753.30
88312 <1% 15 $723.85
87486 <1% 46 $683.23
88142 <1% 30 $680.28
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 306 $636.15
J2785 Injection, regadenoson, 0.1 mg <1% 17 $632.26
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 12 $627.21
82533 <1% 40 $617.82
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 83 $607.79
76937 <1% 129 $558.52
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,422 $556.99
82248 <1% 98 $556.20
77300 <1% 15 $542.89
84156 <1% 110 $537.62
A0425 Ground mileage, per statute mile <1% 378 $535.33
J0690 Injection, cefazolin sodium, 500 mg <1% 3,104 $505.96
87631 <1% 13 $500.09
86708 <1% 26 $493.36
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 261 $488.56
99152 <1% 164 $431.11
73090 <1% 65 $419.58
84480 <1% 53 $411.02
99153 Mod sedat endo service >5yrs <1% 148 $400.51
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 204 $384.78
77062 <1% 13 $378.59
0296T <1% 14 $352.28
84481 <1% 12 $348.59
J1644 Injection, heparin sodium, per 1000 units <1% 4,408 $336.29
82950 <1% 41 $326.95
J1040 Injection, methylprednisolone acetate, 80 mg <1% 27 $320.61
86160 <1% 14 $307.06
J3370 Injection, vancomycin hcl, 500 mg <1% 605 $302.87
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 140 $300.65
J0780 Injection, prochlorperazine, up to 10 mg <1% 621 $288.47
84134 <1% 28 $282.17
83002 <1% 12 $266.93
86787 <1% 14 $266.31
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,823 $261.35
88304 <1% 70 $260.09
97166 <1% 28 $258.01
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,371 $255.75
93246 <1% 13 $255.47
87088 <1% 45 $235.70
84165 <1% 13 $221.74
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,596 $213.30
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,704 $199.10
86593 <1% 24 $193.86
82947 <1% 39 $184.05
J1815 Injection, insulin, per 5 units <1% 1,614 $182.14
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,723 $176.14
73562 <1% 25 $173.44
85045 <1% 40 $162.61
J1030 Injection, methylprednisolone acetate, 40 mg <1% 25 $150.42
83525 <1% 13 $147.62
80349 <1% 13 $142.60
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 159 $141.35
0064A <1% 43 $137.50
87581 <1% 46 $132.24
84425 <1% 12 $120.24
86431 <1% 12 $112.68
80329 <1% 20 $112.44
84436 <1% 14 $107.89
88307 <1% 29 $107.22
82977 <1% 14 $107.02
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 853 $103.28
82150 <1% 16 $94.45
73070 <1% 13 $92.52
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 456 $88.95
J7999 Compounded drug, not otherwise classified <1% 795 $87.93
85396 <1% 12 $83.55
82010 <1% 46 $82.73
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,655 $75.63
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 606 $69.61
97116 <1% 25 $68.60
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 42 $67.20
J2060 Injection, lorazepam, 2 mg <1% 404 $62.08
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,416 $53.89
89051 <1% 19 $47.96
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 314 $39.19
A9585 Injection, gadobutrol, 0.1 ml <1% 24 $38.39
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,627 $36.70
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 302 $34.23
J3475 Injection, magnesium sulfate, per 500 mg <1% 560 $33.09
J1170 Injection, hydromorphone, up to 4 mg <1% 90 $31.59
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 540 $28.16
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 50 $26.40
82077 <1% 28 $24.64
C9113 Injection, pantoprazole sodium, per vial <1% 152 $17.04
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 39 $5.45
J7050 Infusion, normal saline solution, 250 cc <1% 206 $4.68
81002 <1% 18 $3.87
J0360 Injection, hydralazine hcl, up to 20 mg <1% 58 $1.68
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 2,996 $0.11
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 200 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 12 $0.00
0051A 0% 21 $0.00
0052A 0% 13 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 309 $0.00
0071A 0% 34 $0.00
0004A 0% 27 $0.00
0054A 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFRIES, RICK (VP FINANCE)
Parent organizationWEST PENN ALLEGHENY HEALTH SYSTEM INC.
Same official

Other billing entities under FRIES, RICK

Full network →
ProviderLocationPaid
Jefferson Regional Medical CenterClairton, PA$12.73M
West Penn Allegheny Health System INCPittsburgh, PA$12.69M
West Penn Allegheny Health System INC.Monroeville, PA$8.24M
Alle-Kiski Medical CenterNatrona Heights, PA$6.09M
Canonsburg General HospitalCanonsburg, PA$2.97M
Grove City Medical CenterGrove City, PA$2.17M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.